Legal & General Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,294
Closed -$4.79K 3525
2026
Q1
$4.79K Sell
3,294
-736
-18% -$1.17K ﹤0.01% 3292
2025
Q4
$5.56K Hold
4,030
﹤0.01% 3333
2025
Q3
$11K Hold
4,030
﹤0.01% 3265
2025
Q2
$14.1K Buy
+4,030
New +$15.9K ﹤0.01% 3155
2022
Q3
Sell
-1,993
Closed -$6K 3486
2022
Q2
$6K Sell
1,993
-581
-23% -$1.69K ﹤0.01% 3434
2022
Q1
$8K Hold
2,574
﹤0.01% 3452
2021
Q4
$11K Hold
2,574
﹤0.01% 3445
2021
Q3
$17K Hold
2,574
﹤0.01% 3336
2021
Q2
$41K Buy
+2,574
New +$35.6K ﹤0.01% 3010
2020
Q2
Sell
-2,691
Closed -$5K 3459
2020
Q1
$5K Hold
2,691
﹤0.01% 3270
2019
Q4
$12K Buy
2,691
+531
+25% +$3.3K ﹤0.01% 3270
2019
Q3
$18K Hold
2,160
﹤0.01% 3172
2019
Q2
$24K Hold
2,160
﹤0.01% 3131
2019
Q1
$33K Buy
2,160
+1,190
+123% +$19.7K ﹤0.01% 2890
2018
Q4
$19K Hold
970
﹤0.01% 3105
2018
Q3
$31K Buy
+970
New +$29.5K ﹤0.01% 3009

Other funds holding STIM

Legal & General Group's STIM Position: Q2 2026 in Review

Legal & General Group sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 3,294 shares — an estimated $4.79K sold.

Legal & General Group first reported a position in STIM in Q3 2018 and held it in 16 quarters. The position peaked at $41K in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Legal & General Group reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Legal & General Group sold 3,294 Neuronetics shares in Q2 2026, an estimated $4.79K.
  • Legal & General Group first reported a position in Neuronetics in Q3 2018 and held it in 16 quarters.
  • Legal & General Group's Neuronetics position peaked at $41K in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.